Clinical utility of emerging liquid biomarkers in advanced prostate cancer
Publication date: Available online 25 August 2017Source: Cancer GeneticsAuthor(s): Gillian Vandekerkhove, Kim N. Chi, Alexander W. WyattThe therapeutic landscape of advanced prostate cancer (PCa) has rapidly expanded in recent years. Despite significant improvements in patient overall survival, it remains challenging to determine the optimal therapy and sequence of therapies for individual patients. The development of molecular biomarkers will be key for patient stratification, and for monitoring response and resistance to therapy. In this context, minimally-invasive blood-based “liquid” biopsies are attractive...
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker
Publication date: Available online 24 February 2018Source: Cancer GeneticsAuthor(s): Mersedeh RohanizadeganAbstractDespite all the advances in diagnosis and treatment of breast cancer, a large number of patients suffer from late diagnosis or recurrence of their disease. Current available imaging modalities do not reveal micrometastasis and tumor biopsy is an invasive method to detect early stage or recurrent cancer, signifying the need for an inexpensive, non-invasive diagnostic modality. Cell-free tumor DNA (ctDNA) has been tried for early detection and targeted therapy of breast cancer, but its diagnostic and prognostic ...
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Comparison of 4 commercial kits for the extraction of circulating DNA from plasma
We describe the evaluation of 4 commercial DNA purification kits—QIAamp Circulating Nucleic Acids kit, QIAamp DNA Blood Mini kit, QIAamp Ultrasens Virus kit and the QIASymphony DSP Virus kit—for the extraction of high and low molecular weight DNA from blood plasma. Using qPCR to quantitate endogenous Alu sequences, as well as spiked exogenous high and low molecular weight zebrafish DNA, we found that the Circulating Nucleic Acids kit and the DSP kit were both efficient at purifying DNA from plasma regardless of fragment size, whereas the DNA Blood Mini kit was only able to effectively extract high molecular wei...
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Circulating cell-free DNA for non-invasive cancer management
Publication date: Available online 11 March 2018Source: Cancer GeneticsAuthor(s): Caitlin M. Stewart, Dana W.Y. TsuiCell-free DNA (cfDNA) was first identified in human plasma in 1948 and is thought to be released from cells throughout the body into the circulatory system. In cancer, a portion of the cfDNA originates from tumour cells, referred to as circulating-tumour DNA (ctDNA), and can contain mutations corresponding to the patient's tumour, for instance specific TP53 alleles. Profiling of cfDNA has recently become an area of increasing clinical relevance in oncology, in particular due to advances in the sensitivity of ...
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Identification of gene-specific DNA methylation signature for Colorectal Cancer
ConclusionsWith the six gene-specific DNA methylation signatures, patients in the training set were divided into low-risk and high- risk groups. What's more, gene-specific DNA methylation target genes were highly associated with protein phosphorylation, which indicated that further research on phosphorylation of target gene-coding protein might provide new sight on the treatment of CC. (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Corrigendum to “Potential circulating miRNA signature for early detection of NSCLC” [Cancer Genetics 216–217 (2017) 150–158]
Publication date: Available online 15 June 2018Source: Cancer GeneticsAuthor(s): Ayda Arab, Morteza Karimipoor, Shiva Irani, Arda Kiani, Sirous Zeinali, Elham Tafsiri, Kambiz Sheikhy (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Corrigendum to ``Survey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition'' [Cancer Genet. 221(2018) 38–45]
Publication date: Available online 29 June 2018Source: Cancer GeneticsAuthor(s): C.B. Ripamonti, S. Manoukian, B. Peissel, J. Azzollini, M.L. Carcangiu, P. Radice (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Editorial Board
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Non-invasive early detection of malignant pulmonary nodules by FISH-based sputum test
ConclusionsIn a cohort of patients with highly suspicious lung nodules, the LCD test is a non-invasive option with good sensitivity and a high positive predictive value. A positive LCD test reinforces the need to aggressively pursue a definitive diagnosis of suspicious nodules. (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Clonal neutrophil infiltrates in concurrent Sweet's syndrome and acute myeloid leukemia: A case report and literature review
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Wenbin Mo, Xiaoxue Wang, Yue Wang, Yan Li, Rui ZhangAbstractSweet's syndrome (SS), also known as acute febrile neutrophilic dermatosis is often associated with a hematological malignancy, especially acute myeloid leukemia (AML) and myeloid dysplasia syndrome. Histopathologically, SS is characterized by diffuse infiltrates in the upper dermis, predominantly consisting of mature neutrophils. The origin of neutrophils invading the skin remains unknown. Herein, we report a patient with concurrent acute monoblastic leukemia and SS who initial...
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Challenges in next generation sequencing analysis of somatic mutations in transplant patients
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Hui Chen, Rajyalakshmi Luthra, Keyur P Patel, Mark Routbort, Asif Rashid, Sinchita Roy-Chowdhuri, Alexander Lazar, Russell Broaddus, Jawad Manekia, Rajesh R Singh, Anna YemelyanovaAbstractAnalysis of somatic mutations in solid tumors and hematologic malignancies using targeted next generation sequencing (NGS)-based assays has become part of routine oncology practice as well as clinical trials. The use of paired tumor-normal DNA samples increases confidence of somatic calls. NGS assays that utilize unique patient identifiers (SNP IDs) all...
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

Differentially expressed LncRNAs as potential prognostic biomarkers for glioblastoma
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Mei Shao, Wenyun Liu, Yu WangAbstractGlioblastoma (GBM) is the most common and aggressive brain tumor with the poor clinical outcome. LncRNAs (Long non-coding RNAs) play an important role in the occurrence and development of glioblastoma. We aimed to explore the role that lncRNAs play in regulating glioblastoma and the pathways they are enriched in. The expression data of a total of 516 GBM samples were downloaded from TCGA (The Cancer Genome Atlas). We identified the differentially expressed lncRNAs between cancer and normal tissues a...
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): LB Baughn, MM Meredith, L Oseth, TA Smolarek, B HirschAbstractAcute lymphoblastic leukemia (ALL) represents the most common childhood malignancy. Although survival for pediatric B-ALL has approached 90%, variability in outcome among and within cytogenetically defined subgroups persists. While G-banding and fluorescence in situ hybridization (FISH) have been used to characterize leukemic clones, there is added value of chromosomal microarray and next generation sequencing in screening genome-wide for copy number aberrations, copy neutral ...
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

1. Clinical utility of mate pair sequencing to detect diagnostic and prognostic chromosomal rearrangements and copy number changes in patients with acute myeloid leukemia
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Linda Baughn, Stephanie Smoley, Beth Pitel, George Vasmatzis, Sarah Johnson, James Smadbeck, Jess Peterson, Daniel Van Dyke, Rhett Ketterling, Robert Jenkins, Nicole Hoppman, Hutton Kearney, Patricia Greipp (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

2. Distinct genetic signature of a high risk AML subgroup with ERG amplification
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Iya Znoyko, Cynthia Schandl, Daynna Wolff (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

3. Building risk scores for evaluating survival after hematopoietic cell transplantation for AML using pre-transplant cytogenetic data
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Yi Li, Ted Gooley, Chris Davis, Emily Silgard, Mohamed L. Sorror, Masumi Ueda, Jennifer E. Nyland, Lue Zhao, Min Fang (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

4. Coordinating variant interpretation knowledgebases improves clinical interpretation of genomic variants in cancers
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Alex Wagner, Brian Walsh, Dmitriy Sonkin, Rodrigo Dienstmann, Xuan Shirley Li, Jacques S. Beckmann, Georgia Mayfield, David Tamborero, Nuria Lopez-Bigas, Jeremy Goecks, Adam Margolin, Malachi Griffith, Obi Griffith (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

5. Progress and future of the compendium of Cancer Genome Aberrations (CCGA)
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Jennelle C. Hodge, Linda Cooley, Hui Chen, Fei Yang, Obi Griffith, Linda Baughn, Scott Newman, Daynna J. Wolff (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

6. Human ring chromosome registry: Developing an interactive web resource for constitutional and cancer cytogenomic diagnosis
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Peining Li, Autumn DiAdamo, Brittany Grommisch, Hongyan Chai, Qiping Hu (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

7. Data and knowledge sharing to improve patient care: The VICC and MCG experience
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Ingrid Anderson, Neha Jain, Michele LeNoue-Newton, Christine Micheel, Mia Levy (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

8. A comparative analysis of reimbursement for molecular pathology testing for neoplasia
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Melissa Chiu, Kathleen Kroeger, Xiaoyu Qu, Min Fang (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

9. Integrating clinical microarray analyses in the myeloma diagnostic workup: Rationale for improving patient care with precision medicine while reducing overall cost of testing
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Joyce Murata-Collins, Abbas Padeganeh (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

10. Comprehensive genomic characterization of pediatric B-ALL
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Minjie Luo, Fumin Lin, Xiaonan Zhao, Junxia Tang, Gozde T. Akgumus, Daniel J. Gallo, Edward Romasko, Adam G. Gleason, Lea F. Surrey, Gerald Wertheim, Marilyn M. Li (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

11. Utilization of multimodality testing data to develop an optimal diagnostic algorithm for pediatric leukemia
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Gordana Raca, Matthew Hiemenz, Jianling Ji, Matthew Oberley, Deepa Bhojwani, Jaclyn Biegel (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

12. Pediatric oncology testing in the front-line setting: Utility of the CHLA OncoKids panel
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Jaclyn Biegel, Gordana Raca, Jianling Ji, Jennifer Cotter, Hiroyuki Shimada, Shengmei Zhou, Nicholas Shillingford, Mika Warren, Debra Hawes, Di Tian, Matthew Oberley, Fariba Navid, Rachana Shah, Stephanie Thomas, Nathan Robison, Ashley Margol, Deepa Bhojwani, Girish Dhall, Leo Mascarenhas, David Parham (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

13. Clinical application of whole-genome arrays in diagnostic studies of pediatric solid tumors
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Lina Shao, Amer Heider, Carl Koschmann, Sandra Camelo-Piragua, Raja Rabah (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

14. A novel cytogenomic approach to diagnosis of plasma cell neoplasms
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Mahmoud Aarabi, Faith Davenport, Michaelia Austin, Megan Reed, Jane Casey, Chad Lawrence, Svetlana Yatsenko (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

15. Genomic and clinical characterization of early T-cell precursor acute lymphoblastic lymphoma (ETP-LBL)
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Xinjie Xu, Christian N. Paxton, Robert J. Hayashi, Sherrie L. Perkins, Rodney R. Miles (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

16. Australian AIEOP-BFM 2009 acute lymphoblastic leukaemia high-risk findings – Enrichment of IKZF1 deletions and other curious findings
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Nadine Berry, Rodney J. Scott, Rosemary Sutton, Toby N. Trahair, Philip Rowlings, Anoop K. Enjeti (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

17. Application of next-generation sequencing in diagnosis of patients with MDS and AML
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Jing Li, Jinxia Hao, Juan Li, Di Wu, Mei Zhang (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

18. ALLELE: A consortium for prospective genomics and functional diagnostics to guide patient care and trial analysis in newly-diagnosed glioblastoma
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Adrian M. Dubuc, Mehdi Touat, David M. Meredith, Sarah C. Gaffey, Jack E. Geduldig, Shakt Ramkissoon, John F. de Groot, Evanthia Galanis, Andrew B. Lassman, Burt Nabors, Isabel Arrilaga-Romany, E. Antonio Chiocca, Sandro Santagata, David Schiff, Manmeet Ahluwalia, Howard Colman, Jann Drappatz, Brian M. Alexander, Patrick Y. Wen, Keith L. Ligon (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

19. Evidence-based review of genomic aberrations in T-ALL: Strategy and progress of CGC T-ALL Working Group
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Yassmine Akkari, Linda Baugn, Helene Bruyere, Tanner Hagelstrom, Beth Pitel, Gordana Raca, Teresa Smolarek, Ashwini Yenamandra, Matthew Meredith (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

20. Current concepts in breast cancer genomics: An evidence based review from the Cancer Genomics Consortium (CGC) Breast Cancer Workgroup
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Katherine Geiersbach, Yajuan Liu, Gloria Haskell, Hui Chen, Xinyan Lu, Karen Swisshlem, Rajyasree Emmadi, Min Fang (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

53. Clinical utility of single-gene ultra-deep coverage NGS assay for TP53 mutations for detection of low-level mutations
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Rashmi Kanagal-Shamanna, Meenakshi Mehrotra, Bedia Barkoh, Saradhi Mallampati, Ana Maria Bolivar, Wei Chen, Mark Routbort, Keyur Patel, L. Jeffrey Medeiros, Rajyalakshmi Luthra (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

22. Clinical utility of integrated genomic profiling in pediatric brain tumor
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Fumin Lin, Fengqi Chang, Lea Surrey, Gozde Akgumus, Daniel Gallo, Kajia Cao, Mariarita Santi, Angela Waanders, Marilyn Li (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

23. Low-coverage whole genome sequencing revealed a deletion on chromosome 17p, carrying TP53, that suggests poor survival in stage III colorectal cancer
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Paul Van Hummelen, Li Charlie Xia, HoJoon Lee, Matthew Kubit, Christina Wood Bouwens, GiWon Shin, Stephanie Greer, John Bell, Sue Grimes, Billy Lau, Lucas Johnson, Noemi Andor, Kenneth Day, Mickey Miller, Helaman Escobar, Lincoln Nadauld, Hanlee P. Ji (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

24. Integrated analysis and clinical interpretation of CNV, LOH, and sequence variants of FFPE cancer samples profiled on a solid tumor NGS panel
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Sarah Murray, Shalini Verma, Raja Keshavan, Soheil Shams (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

25. RNAseq analysis of PD-L1 expression in colorectal and endometrial tumors and correlation with microsatellite instability
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Maggie Diguardo, Shabnam Zarei, Rory Jackson, Asha Nair, Jaime Davila, Kevin Halling (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

26. pVACtools: Computational selection and visualization of neoantigens for personalized cancer vaccine design
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Susanna Kiwala, Jasreet Hundal, Joshua McMichael, Yang-Yang Feng, Christopher A. Miller, Aaron Graubert, Amber Wollam, Connor Liu, Jonas Neichin, Megan Neveau, Jason Walker, Elaine R. Mardis, Obi L. Griffith, Malachi Griffith (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

27. Biomarker driven clinical trial curation and search
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Michele LeNoue-Newton, Neha Jain, Ingrid Anderson, Christine Micheel, Mia Levy (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

28. Creation, maintenance, and utility of a comprehensive and informative pan-cancer gene list to aid in interpretation of whole genomes in cancer
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Beth A. Pitel, Troy J. Gliem, Shannon M. Knight, Christopher D. Zysk, Benjamin R. Kipp, Katherine B. Geiersbach, Patricia T. Greipp, Hutton M. Kearney, Linda B. Baughn (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

29. Integrating ClinGen somatic cancer variant description standards into crowdsourced curation technology via CIViC database for ClinVar submission
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Arpad Danos, Deborah Ritter, Kilannin Krysiak, Dmitriy Sonkin, Christine Micheel, Matthew McCoy, Shruti Rao, Gordana Raca, Simina Boca, Angshumoy Roy, Nikoletta Sidiropoulos, Dara Aisner, Annette Leon, Alex Wagner, Xuan Shirley Li, Erica Barnell, Joshua McMichael, Susanna Kiwala, Adam Coffman, Lynzey Kujan (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

30. Clinical utility of NGS in the understanding of crosstalk between nuclear cancer genes and mitochondrial genome in tumorigenesis
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Pei Zhao, Hao Wang, Hong-Zheng Dai, Tzu-Wei Yang, Lee-Jun Wong (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

31. Transcriptional alterations to blood monocytes in breast cancer reveal down regulation of anti-cancer pathways
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Amy Robinson, Dylan Skola, Luca Cassetta, Calum Bain, Peter Louwe, Ruairi Lynch, Steve Jenkins, Chris Glass, Jeff Pollard (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

32. Chronic lymphocytic leukemia patients who develop resistance to Bruton Tyrosine Kinase (BTK) inhibitors demonstrate heterogeneous patterns of clonal evolution
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Rashmi Kanagal-Shamanna, Preetesh Jain, Keyur Patel, Carlos Bueso-Ramos, Rajyalakshmi Luthra, Mark Routbort, Zeev Estrov, William Wierda, L. Jeffrey Medeiros (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

33. Chromosomal abnormalities detected in clinical CMA testing of atypical melanocytic proliferations
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Edward Hughes, Michael Johnston, Konstantinos Linos, Robert LeBlanc, Joel Lefferts (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

34. Genome-wide mosaicism, chimerism, and contamination: Recognizing and interpreting genotyping patterns from SNP arrays
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Laura K. Conlin, Minjie Luo, Brooke Weckselblatt, Kelly A. Rafferty, Jennifer Kalish, Elaine H. Zackai, Matthew A. Dulik, Nancy B. Spinner (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

35. PLOIDY and the array
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Jennifer Hauenstein, Adrianna Liebenberg, Beth Matthews, Cynthia O'Hare, Kim Thompson, Christina Fox Gramlich, Faith Sheff, Enrique Vigo, Carol Phillips, Jean Williams, Kristin Deeb, Stewart Neill, Debra Saxe (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

36. FDA approved versus laboratory developed test: An exercise in comparisons utilizing UroVysion evaluation for bladder cancer
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Christopher From, Christine Donovan, Ann Stampalia, Catherine Morgan, Sharon Wang, Rong Staley, Christine Disteche, Yajuan Liu, Min Fang (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research

37. Clinical validation of somatic alterations in solid tumors by next generation sequencing
Publication date: October 2018Source: Cancer Genetics, Volumes 226–227Author(s): Xia Li, Bryan Austin, Michael Donovan, Janet Orton, Guang Liu (Source: Cancer Genetics)
Source: Cancer Genetics - July 10, 2018 Category: Cancer & Oncology Source Type: research